These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30459162)

  • 1. Germline Genetics of Prostate Cancer: Time to Incorporate Genetics into Early Detection Tools.
    Fantus RJ; Helfand BT
    Clin Chem; 2019 Jan; 65(1):74-79. PubMed ID: 30459162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
    Liss MA; Xu J; Chen H; Kader AK
    Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of prostate cancer and its utility in treatment and screening.
    Benafif S; Ni Raghallaigh H; McHugh J; Eeles R
    Adv Genet; 2021; 108():147-199. PubMed ID: 34844712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
    J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of genetic risk score with family history for estimating prostate cancer risk.
    Helfand BT
    Asian J Androl; 2016; 18(4):515-9. PubMed ID: 27004541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical validity and utility of genetic risk scores in prostate cancer.
    Helfand BT; Kearns J; Conran C; Xu J
    Asian J Androl; 2016; 18(4):509-14. PubMed ID: 27297129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Cancer Screening in a New Era of Genetics.
    Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS
    Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Predisposition.
    Bhanji Y; Isaacs WB; Xu J; Cooney KA
    Urol Clin North Am; 2021 Aug; 48(3):283-296. PubMed ID: 34210485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline genetics in localized prostate cancer.
    Ryan ST; Nguyen V; Bree KK; Holst DD; Kader AK
    Curr Opin Urol; 2019 Jul; 29(4):326-333. PubMed ID: 31116139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Cancer Germline Variations and Implications for Screening and Treatment.
    Dias A; Kote-Jarai Z; Mikropoulos C; Eeles R
    Cold Spring Harb Perspect Med; 2018 Sep; 8(9):. PubMed ID: 29101112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial outcomes and insights from a novel high-risk prostate cancer screening clinic.
    Harper JB; Greenberg SE; Hunt TC; Cooney KA; O'Neil BB
    Prostate; 2023 Feb; 83(2):151-157. PubMed ID: 36207779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.
    Benafif S; Ni Raghallaigh H; McGrowder E; Saunders EJ; Brook MN; Saya S; Rageevakumar R; Wakerell S; James D; Chamberlain A; Taylor N; Hogben M; Benton B; D'Mello L; Myhill K; Mikropoulos C; Bowen-Perkins H; Rafi I; Ferris M; Beattie A; Kuganolipava S; Sevenoaks T; Bower J; Kumar P; Hazell S; deSouza NM; Antoniou A; Bancroft E; Kote-Jarai Z; Eeles R
    BJU Int; 2022 Mar; 129(3):325-336. PubMed ID: 34214236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.
    Seibert TM; Garraway IP; Plym A; Mahal BA; Giri V; Jacobs MF; Cheng HH; Loeb S; Helfand BT; Eeles RA; Morgan TM
    Eur Urol; 2023 Mar; 83(3):241-248. PubMed ID: 36609003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
    Loeb S; Giri VN
    Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of genetic testing in prostate cancer screening, diagnosis, and treatment.
    de la Calle CM; Bhanji Y; Pavlovich CP; Isaacs WB
    Curr Opin Oncol; 2022 May; 34(3):212-218. PubMed ID: 35238838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.
    Rumpf F; Plym A; Vaselkiv JB; Penney KL; Preston MA; Kibel AS; Mucci LA; Salari K
    J Urol; 2024 Jun; 211(6):754-764. PubMed ID: 38598641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic factors influencing prostate cancer risk in Norwegian men.
    Chen H; Ewing CM; Zheng S; Grindedaal EM; Cooney KA; Wiley K; Djurovic S; Andreassen OA; Axcrona K; Mills IG; Xu J; Maehle L; Fosså SD; Isaacs WB
    Prostate; 2018 Feb; 78(3):186-192. PubMed ID: 29181843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.
    Briollais L; Ozcelik H; Xu J; Kwiatkowski M; Lalonde E; Sendorek DH; Fleshner NE; Recker F; Kuk C; Olkhov-Mitsel E; Savas S; Hanna S; Juvet T; Hunter GA; Friedlander M; Li H; Chadwick K; Prassas I; Soosaipillai A; Randazzo M; Trachtenberg J; Toi A; Shiah YJ; Fraser M; van der Kwast T; Bristow RG; Bapat B; Diamandis EP; Boutros PC; Zlotta AR
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening.
    Byrne L; Toland AE
    Urol Clin North Am; 2021 Aug; 48(3):387-399. PubMed ID: 34210493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Insights on Genetic Testing in Primary Prostate Cancer.
    Kafka M; Surcel C; Heidegger I
    Mol Diagn Ther; 2021 Jul; 25(4):425-438. PubMed ID: 34118026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.